Streetbeat News

Regulatory

DRLL

WEEI

XOM

ExxonMobil's $1.28 billion asset sale to Seplat Energy in Nigeria is nearing completion, pending ministerial approval. The deal, initially announced in 2022, faced delays due to regulatory issues and opposition from NNPC. ExxonMobil plans further investments in Nigeria's oil sector.

Portfolio Pulse from Lekha Gupta

October 01, 2024 | 2:29 pm

BCS

The Commodity Futures Trading Commission (CFTC) has filed and simultaneously settled charges against Barclays for swap reporting violations. Barclays has been ordered to pay a $4 million penalty.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:27 pm

SPY

USO

The US market is experiencing volatility due to a dockworkers strike and rising oil prices amid Middle East tensions. Reports of a potential Iranian attack on Israel are contributing to the uncertainty.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:08 pm

EIS

ISRA

SPY

USO

The U.S. government is actively supporting Israel's defensive preparations against potential attacks from Iran. A direct military attack from Iran on Israel would result in severe consequences for Iran.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:44 pm

LLY

Eli Lilly is planning new trials for its weight-loss drugs, Mounjaro and Zepbound, targeting non-obese patients. The company aims to explore the use of these drugs for health maintenance and prevention of conditions like diabetes. Eli Lilly is also discouraging the off-label use of Zepbound for cosmetic purposes.

Portfolio Pulse from Vandana Singh

October 01, 2024 | 1:36 pm

META

Meta Platforms Inc. and Mark Zuckerberg are facing an investor lawsuit over alleged misstatements about content management, particularly regarding Instagram's impact on young users. A federal court has partially denied a motion to dismiss the case.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:35 pm

SGMT

Sagimet Biosciences shares rose following the FDA's Breakthrough Therapy Designation for Denifanstat, targeting noncirrhotic metabolic dysfunction associated steatohepatitis with liver fibrosis.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:28 pm

HYPR

The SAFE MRI ECMO study, published on September 29, evaluated the use of Hyperfine's ultra-low-field portable MR imaging system on ICU patients undergoing ECMO with a high risk of acute brain injury.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:07 pm

PTCT

PTC Therapeutics announced that the FDA has accepted its New Drug Application (NDA) for Sepiapterin, a treatment for both pediatric and adult patients with Phenylketonuria (PKU). This marks a significant step forward in the approval process for this potential new treatment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:03 pm

ADD

Color Star Technology has regained compliance with Nasdaq's minimum bid price rule by maintaining a stock price of at least $1.00 for 10 consecutive days.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:01 pm